Production assistance for cellular therapies (PACT)- cell processing facilities
Ended Awarded Last action
- Contract number
- HHSN26800001
- Awardee
-
Beckman Research Institute Of The City Of Hope UEI NPH1VN32EWN5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $872,250
Award facts
- Opportunity
-
- NHLBIECBHB201609JB Solicitation number
- Contract value 100% obligated
- $872,250.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55455, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $183,282 | |
| Exercise an Option | $180,061 | |
| Exercise an Option | $179,503 | |
| Exercise an Option | $173,320 | |
| Original award | $156,084 |
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $872,250 to the Beckman Research Institute of the City of Hope, a nonprofit medical research organization based in Duarte, California. This contract was issued under the Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities master IDIQ and covers Administrative and Regulatory Program Support Services under Task Area #1. The award was made on August 1, 2016, with a completion date of June 30, 2021, and is structured as a firm-fixed-price contract with no set-aside designation. The work is being performed in Minneapolis, Minnesota.
The Beckman Research Institute was selected to support cellular therapy production infrastructure development, leveraging its established expertise in advanced biomedical research and translational science. As a registered federal contractor since 2001, the institute brings significant capabilities in research and development services across multiple disciplines, including immunotherapy and personalized medicine. This engagement aligns with the NHLBI's mission to support the development of cellular therapy technologies and manufacturing capacity, while the institute's experience delivering specialized research services and regulatory support positions it well to advance the agency's cellular therapies program objectives.
Quick answers
Who was awarded contract HHSN26800001?
HHSN26800001 was awarded to Beckman Research Institute Of The City Of Hope by National Heart Lung and Blood Institute (National Institutes of Health) on August 1, 2016.
How much is contract HHSN26800001 worth?
The government has obligated $872,250 on HHSN26800001.
Is contract HHSN26800001 an order under another contract?
Yes. HHSN26800001 is a delivery order under HHSN268201600011I, an indefinite delivery contract, on Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract HHSN26800001 competed?
The extent of competition for HHSN26800001 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award